These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38101427)

  • 21. A roadmap for familial hypercholesterolaemia control.
    Pereira AC
    Lancet Digit Health; 2019 Dec; 1(8):e376-e377. PubMed ID: 33323213
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for familial hypercholesterolaemia.
    Calonge N; Guirguis-Blake J
    BMJ; 2007 Sep; 335(7620):573-4. PubMed ID: 17884865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further response to 'Decision to reject screening for familial hypercholesterolaemia is flawed' by Wald and Martin.
    Wald DS; Martin AC
    Arch Dis Child; 2022 Jan; 107(1):102-103. PubMed ID: 34656980
    [No Abstract]   [Full Text] [Related]  

  • 24. Decision to reject screening for familial hypercholesterolaemia is flawed.
    Wald DS; Martin AC
    Arch Dis Child; 2021 Jun; 106(6):525-526. PubMed ID: 32601084
    [No Abstract]   [Full Text] [Related]  

  • 25. Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data.
    Myers KD; Knowles JW; Staszak D; Shapiro MD; Howard W; Yadava M; Zuzick D; Williamson L; Shah NH; Banda JM; Leader J; Cromwell WC; Trautman E; Murray MF; Baum SJ; Myers S; Gidding SS; Wilemon K; Rader DJ
    Lancet Digit Health; 2019 Dec; 1(8):e393-e402. PubMed ID: 33323221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Familial hypercholesterolemia in children. A management program. Procedures for diagnosis and treatment in our pediatric departments].
    Ose L; Søvik O; Vesterhus P; Wefring KW; Aagenaes O
    Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3514. PubMed ID: 7491607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial hypercholesterolaemia: Child-parent screening may have adverse psychological effects.
    Hopcroft KA
    BMJ; 2007 Oct; 335(7622):683. PubMed ID: 17916819
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    BMJ; 2002 Jun; 324(7349):1303. PubMed ID: 12039822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care.
    Weng S; Kai J; Akyea R; Qureshi N
    Lancet Public Health; 2019 May; 4(5):e256-e264. PubMed ID: 31054643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic.
    Stempel H; Dodge A; Marriott E; Peterson AL
    J Pediatr; 2016 Nov; 178():285-287. PubMed ID: 27592098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidance on the management of familial hypercholesterolaemia in Hong Kong: an expert panel consensus viewpoin.
    Tomlinson B; Chan JC; Chan WB; Chen WW; Chow FC; Li SK; Kong AP; Ma RC; Siu DC; Tan KC; Wong LK; Yeung VT; But BW; Cheung PT; Fu CC; Tung JY; Wong WC; Yau HC
    Hong Kong Med J; 2018 Aug; 24(4):408-415. PubMed ID: 30100583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A European screening programme for familial hypercholesterolaemia: a call to action.
    Gielen S; Weingärtner O
    Eur J Prev Cardiol; 2024 Aug; 31(10):1199-1202. PubMed ID: 36718096
    [No Abstract]   [Full Text] [Related]  

  • 33. Universal screening for familial hypercholesterolaemia in newborns: Time for general practice to contribute.
    Brett T
    Aust J Gen Pract; 2023 Apr; 52(4):246-248. PubMed ID: 37021452
    [No Abstract]   [Full Text] [Related]  

  • 34. [Screening of school children for familial hypercholesterolemia].
    Jepsen BS; Micic S; Hansen B; Larsen SO; Pedersen BN; Skovby F
    Ugeskr Laeger; 1994 Mar; 156(13):1962-4. PubMed ID: 8009690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetics and screening of familial hypercholesterolaemia.
    Henderson R; O'Kane M; McGilligan V; Watterson S
    J Biomed Sci; 2016 Apr; 23():39. PubMed ID: 27084339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High specificity makes DNA screening the method of choice for diagnosis of familial hypercholesterolaemia.
    Kotze MJ
    S Afr Med J; 2001 Dec; 91(12):1042. PubMed ID: 11845598
    [No Abstract]   [Full Text] [Related]  

  • 37. Familial hypercholesterolaemia: screening needs a fresh approach.
    Wald DS; Bestwick JP; Wald NJ
    BMJ; 2007 Nov; 335(7628):1007-8. PubMed ID: 18006971
    [No Abstract]   [Full Text] [Related]  

  • 38. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands.
    Umans-Eckenhausen MA; Defesche JC; Sijbrands EJ; Scheerder RL; Kastelein JJ
    Lancet; 2001 Jan; 357(9251):165-8. PubMed ID: 11213091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
    Marks D; Thorogood M; Neil SM; Humphries SE; Neil HA
    J Med Screen; 2006; 13(3):156-9. PubMed ID: 17007658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for familial hypercholesterolaemia. Funding is difficult to obtain but screening can be international.
    Tomlinson B; Lan IW; Hamilton-Craig I
    BMJ; 2001 Apr; 322(7293):1061-2. PubMed ID: 11349660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.